PTPN1
Overview
PTPN1 (PTP1B) is a tyrosine phosphatase and negative regulator of JAK/STAT signaling. In the corpus it is a classic Hodgkin lymphoma driver and one of the temporally earliest pathogenic events in cHL.
Alterations observed in the corpus
- Mutated in 8% of classic Hodgkin lymphoma cases across 61 WGS/WES-profiled patients PMID:36723991.
- Evolutionary timing analysis placed PTPN1 driver mutations (together with B2M, BCL7A, GNA13) before large chromosomal gains and whole-genome duplication, making it an early event in cHL pathogenesis PMID:36723991.
Cancer types (linked)
- Classic Hodgkin lymphoma (CHL) — 8% mutation frequency; early driver PMID:36723991.
Co-occurrence and mutual exclusivity
- Grouped with B2M, BCL7A, GNA13 as early drivers preceding WGD PMID:36723991.
Therapeutic relevance
- No direct therapeutic link reported in the corpus.
Open questions
- How early PTPN1 events in cHL relate to equivalent early events in DLBCL and other AID-driven B-cell lymphomas PMID:36723991.
Sources
This page was processed by crosslinker on 2026-04-08.